Pages that link to "Q39413238"
Jump to navigation
Jump to search
The following pages link to Ketamine Treatment and Global Brain Connectivity in Major Depression (Q39413238):
Displaying 50 items.
- Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampal-prefrontal cortex dysconnectivity (Q33812862) (← links)
- Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial (Q38371540) (← links)
- Targeting glutamate signalling in depression: progress and prospects (Q38743867) (← links)
- The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder (Q38921265) (← links)
- Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach. (Q38937415) (← links)
- Structural Integrity in the Sustained Antidepressant Effect of Ketamine (Q42109374) (← links)
- Depression in chronic ketamine users: Sex differences and neural bases (Q43787168) (← links)
- Engaging homeostatic plasticity to treat depression (Q47406465) (← links)
- Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic. (Q47636416) (← links)
- Spatiotemporal, metabolic, and therapeutic characterization of altered functional connectivity in major depressive disorder. (Q47653644) (← links)
- Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations (Q47658615) (← links)
- Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens. (Q47682915) (← links)
- Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action (Q47734586) (← links)
- Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature. (Q49712840) (← links)
- Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. (Q53080731) (← links)
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation? (Q56453443) (← links)
- The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder (Q57407197) (← links)
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration (Q57461576) (← links)
- Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor (Q57785354) (← links)
- Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects (Q57796889) (← links)
- Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients (Q58213311) (← links)
- Posttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat Veterans (Q58213313) (← links)
- The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects (Q58213859) (← links)
- Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment (Q58213868) (← links)
- Lower synaptic density is associated with depression severity and network alterations (Q64077366) (← links)
- Reduced Salience and Enhanced Central Executive Connectivity Following PTSD Treatment (Q64112852) (← links)
- Global connectivity of the fronto-parietal cognitive control network is related to depression symptoms in the general population. (Q64926295) (← links)
- Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder. (Q64946597) (← links)
- Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics? (Q88116766) (← links)
- A brain network model for depression: From symptom understanding to disease intervention (Q89184962) (← links)
- Translating molecular and neuroendocrine findings in posttraumatic stress disorder and resilience to novel therapies (Q89716254) (← links)
- Resting-state brain functional connectivity in patients with chronic pain who responded to subanesthetic-dose ketamine (Q95002824) (← links)
- Adjunct ketamine treatment of depression in treatment-resistant schizophrenia patients is unsatisfactory in pilot and secondary follow-up studies (Q90340369) (← links)
- Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression (Q90354161) (← links)
- Efficacy of ketamine therapy in the treatment of depression (Q90446677) (← links)
- Functional plasticity of the dorsomedial prefrontal cortex in depression reorganized by electroconvulsive therapy: Validation in two independent samples (Q91625171) (← links)
- Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model (Q91698159) (← links)
- Ketamine: A Paradigm Shift for Depression Research and Treatment (Q92192294) (← links)
- Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks (Q92483293) (← links)
- Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function (Q92512363) (← links)
- A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants (Q92519527) (← links)
- Increased Cortical Thickness in Patients With Major Depressive Disorder Following Antidepressant Treatment (Q92648535) (← links)
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments (Q92849602) (← links)
- Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment (Q93033299) (← links)
- Differences between ketamine's short-term and long-term effects on brain circuitry in depression (Q93115999) (← links)
- Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments (Q93177074) (← links)
- Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers (Q95642618) (← links)
- The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder (Q97520398) (← links)
- Modulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression (Q98176886) (← links)
- All roads lead to the default-mode network-global source of DMN abnormalities in major depressive disorder (Q98188009) (← links)